In AC, Ki-67 expression was considerably reduced in 88% (14/16), 79% (15/19) and 82% (14/17) of all corresponding tumor samples in response to carboplatin, vinorelbine or gemcitabine, respectively. This evidence concerns the gene MKI67 and neoplasm.